Optimizing the Safe Washout Period for Liver Transplantation Following Immune Checkpoint Inhibitors with Atezolizumab, Nivolumab, or Pembrolizumab

Autor: Kuo, Fang-Cheng, Chen, Cheng-Yen, Lin, Niang-Cheng, Liu, Chinsu, Hsia, Cheng-Yuan, Loong, Che-Chuan
Zdroj: In Transplantation Proceedings May 2023 55(4):878-883
Databáze: ScienceDirect